PL3856213T3 - Sposoby leczenia zakażenia z zastosowaniem bakterii - Google Patents

Sposoby leczenia zakażenia z zastosowaniem bakterii

Info

Publication number
PL3856213T3
PL3856213T3 PL19866580.4T PL19866580T PL3856213T3 PL 3856213 T3 PL3856213 T3 PL 3856213T3 PL 19866580 T PL19866580 T PL 19866580T PL 3856213 T3 PL3856213 T3 PL 3856213T3
Authority
PL
Poland
Prior art keywords
infections
bacteria
treatment
methods
Prior art date
Application number
PL19866580.4T
Other languages
English (en)
Inventor
Michael J. Newman
Original Assignee
Indaptus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indaptus Therapeutics, Inc. filed Critical Indaptus Therapeutics, Inc.
Publication of PL3856213T3 publication Critical patent/PL3856213T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL19866580.4T 2018-09-27 2019-09-26 Sposoby leczenia zakażenia z zastosowaniem bakterii PL3856213T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862737762P 2018-09-27 2018-09-27
PCT/US2019/053289 WO2020069211A1 (en) 2018-09-27 2019-09-26 Methods of treatment of infections using bacteria

Publications (1)

Publication Number Publication Date
PL3856213T3 true PL3856213T3 (pl) 2024-07-08

Family

ID=69947978

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19866580.4T PL3856213T3 (pl) 2018-09-27 2019-09-26 Sposoby leczenia zakażenia z zastosowaniem bakterii

Country Status (16)

Country Link
US (2) US11147844B2 (pl)
EP (1) EP3856213B1 (pl)
JP (1) JP2022502439A (pl)
KR (1) KR20210068462A (pl)
CN (1) CN112770764A (pl)
AU (1) AU2019347502A1 (pl)
BR (1) BR112021005762A2 (pl)
CA (1) CA3114110A1 (pl)
DK (1) DK3856213T3 (pl)
EA (1) EA202190546A1 (pl)
FI (1) FI3856213T3 (pl)
IL (1) IL281775A (pl)
MX (1) MX2021003551A (pl)
PL (1) PL3856213T3 (pl)
PT (1) PT3856213T (pl)
WO (1) WO2020069211A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045498B (zh) * 2021-03-24 2023-01-24 江苏食品药品职业技术学院 一种1,5-二芳基吡唑衍生物、合成方法及用途
CN114717178A (zh) * 2022-03-03 2022-07-08 中国医学科学院医学生物学研究所 一种树鼩睾丸间质细胞的分离培养方法及其应用
US20240075123A1 (en) * 2022-11-17 2024-03-07 Indaptus Therapeutics, Inc. Treatment of cancers and infectious diseases with killed intact bacteria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997881A (en) 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
ITRM20030394A1 (it) * 2003-08-12 2005-02-13 Maria Gabriella Santoro Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
EA030573B1 (ru) * 2013-01-02 2018-08-31 Дикой Байосистемз, Инк. Композиции и способы для лечения рака с применением бактерий
US10335454B2 (en) * 2014-12-18 2019-07-02 Helperby Therapeutics Limited Combination and use
JP2020516318A (ja) * 2017-04-17 2020-06-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 操作された共生細菌及び使用方法
CN107184613A (zh) * 2017-05-23 2017-09-22 山东大学 一种促进乙型肝炎病毒清除的益生菌组合物及其应用

Also Published As

Publication number Publication date
US20200101119A1 (en) 2020-04-02
CN112770764A (zh) 2021-05-07
JP2022502439A (ja) 2022-01-11
AU2019347502A1 (en) 2021-04-22
FI3856213T3 (fi) 2024-05-30
EP3856213A4 (en) 2022-07-06
EP3856213A1 (en) 2021-08-04
WO2020069211A1 (en) 2020-04-02
DK3856213T3 (da) 2024-05-27
EP3856213B1 (en) 2024-03-06
MX2021003551A (es) 2021-08-16
US20220031768A1 (en) 2022-02-03
EA202190546A1 (ru) 2021-09-10
KR20210068462A (ko) 2021-06-09
CA3114110A1 (en) 2020-04-02
PT3856213T (pt) 2024-06-03
US11147844B2 (en) 2021-10-19
IL281775A (en) 2021-05-31
BR112021005762A2 (pt) 2021-06-29

Similar Documents

Publication Publication Date Title
HRP20190580T1 (hr) Kombinirana terapija radi liječenja rezistentnih bakterijskih infekcija
HK1249432A1 (zh) 治療細菌感染的方法
GB201804514D0 (en) Treatment of pyroptosis
IL281775A (en) Methods of treating infections using bacteria
EP3383857A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
GB201804515D0 (en) Treatment of necroptosis
ZA202002069B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
IL290915A (en) Bacterial buginosis treatment
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
DK3630111T3 (en) Compounds and methods for treating bacterial infections
EP3856747C0 (en) SUBSTITUTE PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
SG11202003009QA (en) Methods of treating bacterial infections
SG11202105877YA (en) Method of treatment
RS64891B1 (sr) Lečenje upale pluća
GB201801249D0 (en) Methods of treatment
GB201820236D0 (en) Method of treatment
GB201820157D0 (en) Method of treatment
GB201806569D0 (en) Method of treatment
GB201804021D0 (en) Method of treatment
GB201619704D0 (en) Treatment of pathogenic infections